| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Mitotic checkpoint serine/threonine-protein kinase BUB1 |
|---|
| Ligand | BDBM379090 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Bub1 Kinase Assay |
|---|
| IC50 | 11.0±n/a nM |
|---|
| Citation |  Hitchcock, M; Mengel, A; Pütter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghänel, J; Lienau, P; Preusse, C; Gnoth, MJ Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases US Patent US10266548 Publication Date 4/23/2019 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Mitotic checkpoint serine/threonine-protein kinase BUB1 |
|---|
| Name: | Mitotic checkpoint serine/threonine-protein kinase BUB1 |
|---|
| Synonyms: | BUB1 | BUB1A | BUB1L | BUB1_HUMAN | hBUB1 |
|---|
| Type: | PROTEIN |
|---|
| Mol. Mass.: | 122372.31 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | ChEMBL_1510603 |
|---|
| Residue: | 1085 |
|---|
| Sequence: | MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKK
KYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASA
VLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGN
NMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKE
KLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKL
HQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPP
VVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSG
AEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTL
PDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGL
PQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDF
TSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEK
SPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQA
EWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEF
QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMER
LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR
MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT
IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR
RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLEC
KRSRK
|
|
|
|---|
| BDBM379090 |
|---|
| n/a |
|---|
| Name | BDBM379090 |
|---|
| Synonyms: | Preparation of formic acid-3-chloro-4-({3-[5-methoxy-4-(pyridin-4-ylamino)pyrimidin-2-yl]-1H-indazol-1-yl}methyl)-N-methylbenzamide (1:1) | US10266548, Example 29-1 | US10266548, Example 29-2 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C26H22ClN7O2 |
|---|
| Mol. Mass. | 499.952 |
|---|
| SMILES | CNC(=O)c1ccc(Cn2nc(-c3ncc(OC)c(Nc4ccncc4)n3)c3ccccc23)c(Cl)c1 |
|---|
| Structure | 
|
|---|
Search and Browse
